Next generation of transfection reagent for rAAV production in suspension.

• High performance: Superior yield for AAV production
• Scalability: Developed for small to large scale manufacturing
• Flexibility: Compatible with commercial culture media
• Trustworthy: #1 transfection supplier of gene and cell therapy
• GMP compliance: GMP grade coming soon

FectoVIR®-AAV is a novel class of animal-free transfection reagent specifically developed for research development up to industrial scale production of recombinant AAV (rAAV) viral vectors in suspension HEK-293 cell types.

FectoVIR®-AAV transfection reagent guarantees higher rAAV viral titers, improved flexibility and scalability for industrial scale manufacturing.